Funding for Rare Diseases Clinical Research Consortia in the RDCRN (U54; clinical trials optional)
PAR-25-438This NOFO invites new and renewal applications to establish or lead Rare Diseases Clinical Research Consortia within the RDCRN. Projects should advance diagnosis, management, and treatment of rare diseases through collaborative, multi-site, patient-centered translational and clinical research, with emphasis on early identification and clinical trial readiness.
The objective of this Notice of Funding Opportunity (NOFO) is to invite new and renewal applications for the Rare Diseases Clinical Research Consortia (RDCRC) that comprise the Rare Diseases Clinical Research Network (RDCRN). The RDCRCs are intended to advance and improve diagnosis, manage…
Source
Awards & funding
Eligibility
Higher Education Institutions - Includes all typesPublic/State Controlled Institutions of Higher EducationPrivate Institutions of Higher EducationNonprofits Other Than Institutions of Higher EducationNonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)Nonprofits wit…
Tags
Supporting links
Documents
Similar opportunities
-
Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
-
R21 funding to prepare rare disease therapies and diagnostics for future clinical trials
-
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
-
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01)
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers